Gilead Sciences (GILD) Current Assets (2009 - 2026)

Gilead Sciences (GILD) has reported Current Assets for 18 consecutive years, with $18.6 billion the latest figure, recorded in Q1 2026.

• Current Assets for Q1 2026 came in at $18.6 billion, up 10.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.6 billion (up 10.3% YoY), and the FY2025 annual result was $18.3 billion, down 4.33% from the prior year.
• Current Assets was $18.6 billion for Q1 2026 at Gilead Sciences, up from $18.3 billion in the prior quarter.
• Over five years, Current Assets peaked at $19.2 billion in Q4 2024 and troughed at $12.3 billion in Q2 2024.
• Average Current Assets over 5 years is $15.3 billion, with a median of $14.7 billion recorded in 2025.
• Year-over-year, Current Assets decreased 13.79% in 2024 and climbed 20.94% in 2025.
• Over 5 years, Current Assets stood at $14.4 billion in 2022, then climbed by 11.37% to $16.1 billion in 2023, then grew by 19.2% to $19.2 billion in 2024, then decreased by 4.33% to $18.3 billion in 2025, then gained by 1.63% to $18.6 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $18.6 billion in Q1 2026, $18.3 billion in Q4 2025, and $17.9 billion in Q3 2025.